{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,13]],"date-time":"2026-08-13T19:30:54Z","timestamp":1786649454608,"version":"build-2736575974"},"reference-count":29,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"2","license":[{"start":{"date-parts":[[2025,5,1]],"date-time":"2025-05-01T00:00:00Z","timestamp":1746057600000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-sa\/4.0"}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2025,5]]},"abstract":"<jats:sec>\n                    <jats:title>Background:<\/jats:title>\n                    <jats:p>Modified electroconvulsive therapy (mECT) is the treatment of choice in suicidality and resistant psychiatric disorders like treatment resistant depression and schizophrenia. A handful of studies with modest sample sizes have shown some effect of mECT on glycemic control and cholesterol levels; however, not a single study has explored the association between mECT and metabolic syndrome.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Aim:<\/jats:title>\n                    <jats:p>To find out the prevalence and clinical corelates of metabolic syndrome in patients receiving mECT.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Materials and Methods:<\/jats:title>\n                    <jats:p>This was a cross-sectional exploratory study in which 89 patients receiving mECT were recruited via systematic random sampling and evaluated for metabolic syndrome by using modified National Cholesterol Education Program Adult Treatment Panel III (NCEP ATP-III) criteria.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results:<\/jats:title>\n                    <jats:p>\n                      The prevalence of metabolic syndrome in patients receiving mECT was 55.06%. The most common metabolic abnormality noted was elevated blood pressure, with increased diastolic blood pressure in 71.9% and elevated systolic blood pressure in 67.42%. We found a significant association between age (\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      &lt; 0.001) and gender of patients on ECT with metabolic syndrome. (\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      = 0.019). Having received mECT\u2019s in past (\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      &lt; 0.001) and a higher number of mECTs (\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      &lt; 0.001) were both significantly associated with metabolic syndrome. Multivariate logistic regression metabolic syndrome was significantly predicted by the number of mECTs [{(unadjusted odds ratio 1.57), (adjusted odds ratio 1.52)}(\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      value &lt; 0.001)}].\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion:<\/jats:title>\n                    <jats:p>Our findings revealed an increased prevalence of metabolic syndrome in mECT population; this emphasizes the importance of screening for metabolic syndrome to reduce the risk of cardiovascular disease and premature death.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.4103\/ipj.ipj_367_24","type":"journal-article","created":{"date-parts":[[2025,7,19]],"date-time":"2025-07-19T08:00:12Z","timestamp":1752912012000},"page":"309-316","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":1,"title":["Prevalence and clinical corelates of metabolic syndrome in patients receiving modified electro-convulsive therapy: An exploratory study from North India"],"prefix":"10.4103","volume":"34","author":[{"given":"Aaliya","family":"Khanam","sequence":"first","affiliation":[{"name":"Department of Psychiatry, Institute of Mental Health and Neurosciences Kashmir, Government Medical College, Srinagar, Jammu and Kashmir, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rajnish","family":"Raj","sequence":"additional","affiliation":[{"name":"Department of Psychiatry, Institute of Mental Health and Neurosciences Kashmir, Government Medical College, Srinagar, Jammu and Kashmir, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zaid Ahmad","family":"Wani","sequence":"additional","affiliation":[{"name":"Department of Psychiatry, Institute of Mental Health and Neurosciences Kashmir, Government Medical College, Srinagar, Jammu and Kashmir, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Inaamul","family":"Haq","sequence":"additional","affiliation":[{"name":"Department of Community Medicine, Institute of Mental Health and Neurosciences Kashmir, Government Medical College, Srinagar, Jammu and Kashmir, India"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2025,7,18]]},"reference":[{"key":"R1-20260422","doi-asserted-by":"crossref","first-page":"786","DOI":"10.3390\/ijms23020786","article-title":"Metabolic syndrome: Updates on pathophysiology and management in 2021","volume":"23","author":"Fahed","year":"2022","journal-title":"Int J Mol Sci"},{"key":"R3-20260422","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s13098-021-00750-4","article-title":"Metabolic syndrome and associated factors among severely ill psychiatric and non-psychiatric patients: A comparative cross-sectional study in Eastern Ethiopia","volume":"13","author":"Fentie","year":"2021","journal-title":"Diabetol Metab Syndr"},{"key":"R4-20260422","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1111\/pcn.12221","article-title":"Changes of metabolic parameters during electroconvulsive treatment of schizophrenia: Preliminary results","volume":"69","author":"Wysoki\u0144ski","year":"2015","journal-title":"Psychiatry Clin Neurosci"},{"key":"R5-20260422","doi-asserted-by":"crossref","first-page":"448","DOI":"10.1186\/s12888-016-1143-8","article-title":"Metabolic syndrome and adverse clinical outcomes in patients with bipolar disorder","volume":"16","author":"Bai","year":"2016","journal-title":"BMC Psychiatry"},{"key":"R6-20260422","doi-asserted-by":"crossref","first-page":"931","DOI":"10.1001\/jamapsychiatry.2013.1394","article-title":"Comorbidities and mortality in bipolar disorder: A Swedish national cohort study","volume":"70","author":"Crump","year":"2013","journal-title":"JAMA Psychiatry"},{"key":"R7-20260422","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1590\/0101-60830000000177","article-title":"Metabolic syndrome in bipolar disorder: Prevalence, demographics and clinical correlates in individuals with bipolar I, bipolar II, and healthy controls","volume":"45","author":"Kocakaya","year":"2018","journal-title":"Arch Clin Psychiatry S\u00e3o Paulo"},{"key":"R8-20260422","doi-asserted-by":"crossref","first-page":"1007","DOI":"10.1016\/j.neuint.2012.07.013","article-title":"The effect of electroconvulsive therapy on blood glucose, creatinine levels, and lipid profile and its association with the type of psychiatric disorders","volume":"61","author":"Ghanizadeh","year":"2012","journal-title":"Neurochem Int"},{"key":"R9-20260422","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1097\/YCT.0000000000000138","article-title":"Neurotransmitters and electroconvulsive therapy","volume":"30","author":"Baldinger","year":"2014","journal-title":"J ECT"},{"key":"R10-20260422","doi-asserted-by":"crossref","first-page":"210","DOI":"10.9758\/cpn.2017.15.3.210","article-title":"How electroconvulsive therapy works?: Understanding the neurobiological mechanisms","volume":"15","author":"Singh","year":"2017","journal-title":"Clin Psychopharmacol Neurosci"},{"key":"R11-20260422","first-page":"e30222","article-title":"Effects of electroconvulsive therapy on glycemic control in type 1 diabetes","volume":"14","author":"Stefan","year":"2022","journal-title":"Cureus"},{"key":"R12-20260422","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/j.neulet.2007.08.018","article-title":"The effects of electroconvulsive therapy on ghrelin, leptin and cholesterol levels in patients with mood disorders","volume":"426","author":"Kurt","year":"2007","journal-title":"Neurosci Lett"},{"key":"R13-20260422","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1097\/00124509-200606000-00009","article-title":"Blood glucose before and after ECT treatments in Type 2 diabetic patients","volume":"22","author":"Rasmussen","year":"2006","journal-title":"J ECT"},{"key":"R14-20260422","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1007\/s00702-022-02475-8","article-title":"Electroconvulsive therapy and adiposity-related parameters in treatment-resistant depressed patients","volume":"129","author":"Maier","year":"2022","journal-title":"J Neural Transm"},{"key":"R16-20260422","doi-asserted-by":"crossref","first-page":"1660","DOI":"10.2337\/dc12-1452","article-title":"Measurement of waist circumference","volume":"36","author":"Ma","year":"2013","journal-title":"Diabetes Care"},{"key":"R17-20260422","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1016\/S0733-8651(01)00009-1","article-title":"Principles and techniques of blood pressure measurement","volume":"20","author":"Pickering","year":"2002","journal-title":"Cardiol Clin"},{"key":"R18-20260422","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1016\/j.genhosppsych.2008.04.009","article-title":"Metabolic syndrome in Italian patients with bipolar disorder","volume":"30","author":"Salvi","year":"2008","journal-title":"Gen Hosp Psychiatry"},{"key":"R19-20260422","doi-asserted-by":"crossref","first-page":"e6955","DOI":"10.1590\/1414-431x20176955","article-title":"Time collection and storage conditions of lipid profile","volume":"51","author":"Fran\u00e7a","year":"2018","journal-title":"Braz J Med Biol Res"},{"key":"R20-20260422","doi-asserted-by":"crossref","first-page":"364","DOI":"10.4103\/2230-8210.131186","article-title":"Prevalence of metabolic syndrome in the family members of women with polycystic ovary syndrome from North India","volume":"18","author":"Shabir","year":"2014","journal-title":"Indian J Endocrinol Metab"},{"key":"R21-20260422","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1176\/appi.ajp.2012.12050620","article-title":"Metabolic syndrome and metabolic abnormalities in bipolar disorder: A meta-analysis of prevalence rates and moderators","volume":"170","author":"Vancampfort","year":"2013","journal-title":"Am J Psychiatry"},{"key":"R22-20260422","doi-asserted-by":"crossref","first-page":"510","DOI":"10.1016\/j.dsx.2018.11.002","article-title":"A comparative study of prevalence and predictors of metabolic syndrome in various psychiatric disorders in state of Haryana: More than 30 years Vs. less than 30 years","volume":"13","author":"Anjum","year":"2019","journal-title":"Diabetes Metab Syndr"},{"key":"R23-20260422","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1016\/j.genhosppsych.2016.12.007","article-title":"Prevalence of metabolic syndrome and its components among patients with various psychiatric diagnoses and treatments: A cross-sectional study","volume":"45","author":"Alosaimi","year":"2017","journal-title":"Gen Hosp Psychiatry"},{"key":"R24-20260422","doi-asserted-by":"crossref","first-page":"1035","DOI":"10.1016\/j.psychres.2012.03.043","article-title":"Prevalence of metabolic syndrome in patients with schizophrenia in India","volume":"200","author":"Grover","year":"2012","journal-title":"Psychiatry Res"},{"key":"R25-20260422","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1016\/j.pnpbp.2011.10.013","article-title":"Prevalence of metabolic syndrome in bipolar disorder: An exploratory study from North India","volume":"36","author":"Grover","year":"2012","journal-title":"Prog Neuropsychopharmacol Biol Psychiatry"},{"key":"R26-20260422","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1111\/j.1464-5491.2010.02998.x","article-title":"Gender differences in prevalence of the metabolic syndrome in Gulf Cooperation Council Countries: A systematic review","volume":"27","author":"Mabry","year":"2010","journal-title":"Diabetic Medicine"},{"key":"R27-20260422","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1186\/1471-2261-14-51","article-title":"Gender-dependent associations between socioeconomic status and metabolic syndrome: A cross-sectional study in the adult Saudi population","volume":"14","author":"Al-Daghri","year":"2014","journal-title":"BMC Cardiovasc Disord"},{"key":"R28-20260422","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1093\/schbul\/sbr148","article-title":"Prevalence of metabolic syndrome and metabolic abnormalities in schizophrenia and related disorders--A systematic review and meta-analysis","volume":"39","author":"Mitchell","year":"2013","journal-title":"Schizophr Bull"},{"key":"R29-20260422","doi-asserted-by":"crossref","first-page":"94","DOI":"10.3389\/fpsyt.2013.00094","article-title":"Electroconvulsive treatment: Hypotheses about mechanisms of action","volume":"4","author":"Fosse","year":"2013","journal-title":"Front Psychiatry"},{"key":"R30-20260422","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1097\/YCT.0000000000000802","article-title":"The cardiovascular side effects of electroconvulsive therapy and their management","volume":"38","author":"Hermida","year":"2022","journal-title":"J ECT"},{"key":"R31-20260422","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1097\/HRP.0000000000000365","article-title":"Electroconvulsive therapy: Mechanisms of action, clinical considerations, and future directions","volume":"31","author":"Kritzer","year":"2023","journal-title":"Harv Rev Psychiatry"}],"container-title":["Industrial Psychiatry Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/10.4103\/ipj.ipj_367_24","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,13]],"date-time":"2026-08-13T18:54:22Z","timestamp":1786647262000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/10.4103\/ipj.ipj_367_24"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,5]]},"references-count":29,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2025]]}},"URL":"https:\/\/doi.org\/10.4103\/ipj.ipj_367_24","relation":{},"ISSN":["0972-6748","0976-2795"],"issn-type":[{"value":"0972-6748","type":"print"},{"value":"0976-2795","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,5]]},"assertion":[{"value":"2024-08-19","name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2024-12-30","name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}}]}}